ChEMBL

ChEMBL
Nilalaman
Paglalarawan	Bayolohikal na database
Nilalamang Uri ng Data	Mga molecule na may tulad ng epekto ng gamot at bayolohikal na aktibidad
Lapat
Sentro ng Pagsasaliksik	European Molecular Biology Laboratory
Laboratoryo	European Bioinformatics Institute
May-akda	John Overington, Puno ng Pangkat 2008-2015
Pangunahing banggit	PMID 21948594
Petsa ng pagkalabas	2009
Pag-abot
Websayt	ChEMBL
Download URL	Downloads
Web service URL	ChEMBL Webservices
Sparql endpoint	ChEMBL EBI-RDF Platform
Gamit
Iba pa
Lisensiya	Nagagamit ang ChEMBL data sa ilalim ng Lisensiya ng Creative Commons Attribution-Share Alike 3.0
Versioning	Chembl_20

Ang ChEMBL o ChEMBLdb ay isang kemikal na database ng mga molecule na bioactibo na may katulad na epekto ng mga gamot.^[1] Ito ay pinangangasiwaan ng European Bioinformatics Institute (EBI), na bahagi ng European Molecular Biology Laboratory (EMBL), na nakabase sa Wellcome Trust Genome Campus, Hinxton, UK.

Nagawa ang database, na dating kilala bilang StARlite, ng isang kompanya ng bioteknolohiya na Inpharmatica Ltd. na kalaunan ay binili ng Galapagos NV. Naibenta naman ang data para sa EMBL noong 2008 na may gantimpala mula sa Wellcome Trust, na nagresulta sa pagkabuo ng pangkat chemogenomic ng ChEMBL sa EMBL-EBI, na pinangungunahan ni John Overington.^[2]^[3]

Tignan din

Talababa

↑ Gaulton, A; atbp. (2011). "ChEMBL: a large-scale bioactivity database for drug discovery". Nucleic Acids Research. 40: D1100-7. doi:10.1093/nar/gkr777. PMC 3245175. PMID 21948594. {{cite journal}}: |access-date= requires |url= (tulong)CS1 maint: date auto-translated (link)
↑ Bender, A (2010). "Databases: Compound bioactivities go public". Nature Chemical Biology. 309 (6): 309. doi:10.1038/nchembio.354. Nakuha noong 2010-11-15.{{cite journal}}: CS1 maint: date auto-translated (link)
↑ Overington J (Abril 2009). "ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI). Interview by Wendy A. Warr". J. Comput. Aided Mol. Des. 23 (4): 195–8. Bibcode:2009JCAMD..23..195W. doi:10.1007/s10822-009-9260-9. PMID 19194660.{{cite journal}}: CS1 maint: date auto-translated (link)

Mga kawing panlabas

ChEMBLdb
Kinase SARfari Naka-arkibo 2016-05-15 sa Wayback Machine.
ChEMBL-Neglected Tropical Disease Archive Naka-arkibo 2017-07-07 sa Wayback Machine.
GPCR SARfari Naka-arkibo 2018-01-26 sa Wayback Machine.
The ChEMBL-og Open data and drug discovery blog run by the ChEMBL team.

[Gaulton-1] Gaulton, A; atbp. (2011). "ChEMBL: a large-scale bioactivity database for drug discovery". Nucleic Acids Research. 40: D1100-7. doi:10.1093/nar/gkr777. PMC 3245175. PMID 21948594. {{cite journal}}: |access-date= requires |url= (tulong)CS1 maint: date auto-translated (link)

[Bender-2] Bender, A (2010). "Databases: Compound bioactivities go public". Nature Chemical Biology. 309 (6): 309. doi:10.1038/nchembio.354. Nakuha noong 2010-11-15.{{cite journal}}: CS1 maint: date auto-translated (link)

[pmid19194660-3] Overington J (Abril 2009). "ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI). Interview by Wendy A. Warr". J. Comput. Aided Mol. Des. 23 (4): 195–8. Bibcode:2009JCAMD..23..195W. doi:10.1007/s10822-009-9260-9. PMID 19194660.{{cite journal}}: CS1 maint: date auto-translated (link)

[1]

[2]

[3]